О государственной корпорации «РОСБИОМЕД»: организационно-правовой аспект

Abstract

Relevance. The introduction of the restrictive political and economic measures against the Russian Federation has led to the fact that imports of a number of means, substances and technologies which are necessary for the develop-ment and normal functioning of healthcare, agriculture, veterinary science and some other socially significant areas have become inaccessible. The current situation makes it necessary to stimulate scientific research and innovation activities aimed at developing and creating analogues of means, substances and technologies purchased abroad until recently. However, the task is possible only if a set of legal, organizational and financial issues is resolved. The purpose of this study is to develop theoretical recommendations for improving legislation that that regulates the creation and implementation of new tools, substances and technologies in medicine, agriculture, veterinary science and other sectors of the national economy. Objectives to establish how the sanctions imposed on Russia affected health care, veterinary science, agriculture and other areas; to identify legal problems that impede the development of scientific and innovative activities of organizations engaged in the development of biotechnologies, medicines, medical products and other means of medical, veterinary and agricultural use; to consider the prospects for the creation of a state corporation that carries out research, innovation, implementation, production activities in the field of biology, medicine and biomedical technologies. Methodology. When writing the work, dialectical-materialistic method, systematic method, methods of analysis and synthesis, formal-legal method were used. The results of the study are theoretical and applied nature and contain suggestions for improving Russian leg-islation in terms of legal regulation of the creation and operation of the state corporation engaged in research, innovation, implementation, production activities in the field of biology, medicine and biomedical technologies. Conclusion. The study provided a rationale for the need to adopt a special federal law, on the basis of which the state corporation "ROSBIOMED".